|
| Status |
Public on Nov 22, 2017 |
| Title |
Integrated target discovery screens identify IL11 as novel therapeutic target for fibrosis |
| Organisms |
Homo sapiens; Mus musculus |
| Experiment type |
Expression profiling by high throughput sequencing
|
| Summary |
This SuperSeries is composed of the SubSeries listed below.
|
| |
|
| Overall design |
Refer to individual Series
|
| |
|
| Citation(s) |
29160304 |
| |
| Submission date |
Mar 28, 2017 |
| Last update date |
May 15, 2019 |
| Contact name |
Sonia Chothani |
| E-mail(s) |
[email protected]
|
| Organization name |
Duke-NUS school of medicine
|
| Lab |
Prof. Stuart Cook
|
| Street address |
8 College Road
|
| City |
Singapore |
| ZIP/Postal code |
169857 |
| Country |
Singapore |
| |
|
| Platforms (3) |
| GPL16791 |
Illumina HiSeq 2500 (Homo sapiens) |
| GPL18573 |
Illumina NextSeq 500 (Homo sapiens) |
| GPL19057 |
Illumina NextSeq 500 (Mus musculus) |
|
| Samples (212)
|
|
| This SuperSeries is composed of the following SubSeries:
|
| GSE96975 |
Integrated target discovery screens identify IL11 as novel therapeutic target for fibrosis [human] |
| GSE96991 |
Integrated target discovery screens identify IL11 as novel therapeutic target for fibrosis [mouse] |
| GSE97358 |
Integrated target discovery screens identify IL11 as novel therapeutic target for fibrosis [168 human cardiac fibroblasts] |
| GSE107909 |
IL-11 is a crucial determinant of cardiovascular fibrosis (mouse single cell) |
|
| Relations |
| BioProject |
PRJNA380739 |
Less...
More...